From: Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Histology | 4-Year RFS or EFS | 4-Year OS | Treatmentb |
---|---|---|---|
FH (with isolated lung nodules) | 85% EFS | 96% | Nephrectomy + lymph node sampling, followed by abdominal XRT,c +/- bilateral pulmonary XRT,d and regimen DD-4A or regimen Me |
FH (no LOH of 1p and 16q) with isolated lung nodules with CR to DD-4A | 80% EFS | 96% | Nephrectomy + lymph node sampling, followed by abdominal XRTc and regimen DD-4A |
FH (no LOH of 1p and 16q) with isolated lung nodules with incomplete response to DD-4A | 99% EFS | 95% | Nephrectomy + lymph node sampling, followed by abdominal XRTc and bilateral pulmonary XRTd and regimen M |
FH (LOH of 1p and 16q) with isolated lung nodules (n = 18) | 100% | 100% | Nephrectomy + lymph node sampling followed by abdominal XRTc and bilateral pulmonary XRTd and regimen M |
FH (with LOH of 1p and/or 16q) (n = 20) | 95% EFS | 100% | Nephrectomy + lymph node sampling, abdominal XRTc radiation to sites of metastases, and regimen M |
FH with extrapulmonary metastases, with or without lung metastases | 76% EFS | 89% | Nephrectomy + lymph node sampling followed by abdominal XRTc, regimen M, and local control of other metastatic sites; if lung metastases are present, bilateral pulmonary XRTd |
FA | 61% EFS | 72% (n = 11) | Nephrectomy + lymph node sampling, followed by abdominal XRT,c radiation to sites of metastases, bilateral pulmonary XRT,d and regimen DD-4A |
DA | 33% EFS | 33% (n = 10) | Immediate nephrectomy + lymph node sampling followed by abdominal XRT,c radiation to sites of metastases, whole-lung XRT,d and regimen I |
DA (preoperative treatment) | 60% EFS | 70% (n = 10) | Preoperative treatment with regimen UH2 followed by nephrectomy + lymph node sampling, followed by abdominal XRT,c radiation to sites of metastases, and whole-lung XRTd |
CR = complete response; DA = diffuse anaplasia; EFS = event-free survival; FA = focal anaplasia; FH = favorable histology; LOH = loss of heterozygosity; OS = overall survival; RFS = relapse-free survival; XRT = radiation therapy.
bFor chemotherapy regimen descriptions, see Table 2.
cAbdominal XRT is planned according to local stage of renal tumor.
dPulmonary XRT is reserved for patients with chest x-ray/chest computed tomography evidence of pulmonary metastases.
eFor more information, see the AREN0533 (NCT00379340) study.
From: Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.